October 27, 2010

NC-based nContact Surgical sews up more than half of $23.1M in equity

Filed under: Regional Venture News — admin @ 3:43 pm

MORRISVILLE,  NC – nContact Surgical, formerly known as Ablatrics Inc., has raised $13.15 million of a targeted $23.15 million equity raise, according to a regulatory filing. nContact makes medical devices for the endoscopic treatment of heart arrhythmias. (more…)

October 26, 2010

Emory, GA Tech tackle head, neck, pancreatic cancers with $4.7M grant

Filed under: Other Regional News — admin @ 6:07 pm

ATLANTA—Researchers at Emory University and the Georgia Institute of Technology will join forces against head and neck cancers and pancreatic cancer using two grants from the National Cancer Institute’s Cancer Nanotechnology Platform Partnerships (CNPP) program. The cooperative five-year grants totaling $4.7 million will be used to develop nanoparticles as diagnostic and therapeutic tools against cancers. (more…)

October 22, 2010

Durham-based Chesson Labs raises more than half of $2M round

Filed under: Regional Venture News — admin @ 3:26 pm

DURHAM, NC – Chesson Laboratory Associates Inc. has raised $1.1 million of a $2 million share offering, according to a regulatory filing. The US Food and Drug Administration cleared the company’s Liquid Bandage product in 2009. (more…)

October 21, 2010

Georgia-based Effcon MXR nabs $522K of targeted $3M raise for glaucoma drug

Filed under: Regional Venture News — admin @ 8:16 pm

MARIETTA, GA – Effcon MXR, a company developing a once-a-day version of a drug used to treat glaucoma, has raised $522,000 of a targeted $3 million raise, according to a regulatory filing. (more…)

October 20, 2010

SEBIO names life science firms presenting at its Investor Forum

Filed under: SEBIO in the News — admin @ 7:05 pm

ATLANTA – Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, has named the best life sciences deals in the Southeast, as determined by a Selection Committee comprised of regional and national venture capitalists.  These companies, both early- and later-stage, will participate in the upcoming SEBIO Investor Forum being held on November 3-4, 2010 at the Ritz-Carlton, Buckhead in Atlanta, Georgia. (more…)

October 19, 2010

Florida-based biotech Vicor Technologies raises $2.7M in debt

Filed under: Regional Venture News — admin @ 4:20 pm

BOCA RATON, FL – Vicor Technologies Inc. (OTCBB: VCRT) has raised $2.72 million of its $2.95 million debt offering, according to a regulatory filing. The company disclosed the financing in a filing with the US Securities and Exchange Commission, which says the the total offering is targeted at $2.95 million. (more…)

October 15, 2010

Alimera Sciences lands $32.5M credit facility for eye disease drug

Filed under: Regional Venture News — admin @ 10:53 am

ATLANTA – Alimera Sciences Inc. (Nasdaq:ALIM)  has obtained a $32.5 million senior secured credit facility to help fund its working capital requirements. The credit facility consists of a $20 million revolving line of credit provided by Silicon Valley Bank and a $12.5 million term loan provided by MidCap Financial, LLC and Silicon Valley Bank. (more…)

October 14, 2010

BioCryst Pharma moving HQ from Birmingham to Durham

Filed under: Other Regional News — admin @ 10:59 am

DURHAM, NC - BioCryst Pharmaceuticals (Nasdaq:BCRX)  is moving its headquarters from Birmingham, AL to Durham, NC, the Birmingham Business Journal reports. (more…)

October 12, 2010

Pfizer acquiring Tennessee-based King Pharmaceuticals for $3.6B

Filed under: Other Regional News — admin @ 11:00 am

BRISTOL, TN – Pfizer Inc.(NYSE: PFE)  and King Pharmaceuticals Inc. (NYSE: KG)have agreed to merge in a deal worth $3.6 billion in cash. (more…)

October 8, 2010

Neuronex launches with $1.5M A round to develop CNS drugs

Filed under: Regional Venture News — admin @ 11:08 am

MORRISVILLE, NC – Neuronex Inc. has raised $1.5 million in Series A funding and was awarded a $250,000 Small Business Research Loan from the North Carolina Biotechnology Center to launch the company focused on developing drugs for central nervous system diseases and disorders. (more…)

Next Page »